{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:39:45Z","timestamp":1793036385410,"version":"4.5.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biologicals"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.biologicals.2026.101913","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:01:50Z","timestamp":1790121710000},"page":"101913","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Development and validation of a quantitative real-time PCR method for determination of residual host DNA in recombinant human C1 esterase inhibitor (rhC1INH)"],"prefix":"10.1016","volume":"96","author":[{"given":"Cong","family":"Cong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianfei","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yali","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayao","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3194-9720","authenticated-orcid":false,"given":"Lanjun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biologicals.2026.101913_bib1","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1021\/ac00009a003","article-title":"Quantitation of DNA and protein impurities in biopharmaceuticals","volume":"63","author":"Briggs","year":"1991","journal-title":"Anal Chem"},{"issue":"4","key":"10.1016\/j.biologicals.2026.101913_bib2","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1006\/biol.1997.0114","article-title":"Risk assessment on the carcinogenic potential of hybridoma cell DNA: implications for residual contaminating cellular DNA in biological products","volume":"25","author":"Dortant","year":"1997","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2026.101913_bib3","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.1016\/j.vaccine.2010.02.099","article-title":"A probabilistic model for risk assessment of residual host cell DNA in biological products","volume":"28","author":"Yang","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2026.101913_bib4","series-title":"WHO technical report series, No. 978, Annex 3","article-title":"Recommendations for the evaluation of animal cell cultures as substrates for the manufacture of biological medicinal products and for the characterization of cell banks","year":"2010"},{"key":"10.1016\/j.biologicals.2026.101913_bib5","series-title":"Guidance for industry: chemistry, manufacturing, and controls (CMC) information for human gene therapy investigational new drug applications (INDs)","year":"2020"},{"key":"10.1016\/j.biologicals.2026.101913_bib7","series-title":"Pharmacopoeia of the People's Republic of China (Volume Three)","first-page":"134","year":"2025"},{"key":"10.1016\/j.biologicals.2026.101913_bib8","series-title":"European pharmacopoeia","first-page":"\u00a72.6","year":"2022"},{"key":"10.1016\/j.biologicals.2026.101913_bib9","series-title":"The United States pharmacopoeia:nucleic acid-based techniques\u2014approaches for detecting trace nucleic acids (residual dna testing)","year":"2021"},{"issue":"1","key":"10.1016\/j.biologicals.2026.101913_bib10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/BF02106177","article-title":"The L1 family of long interspersed repetitive DNA in rabbits: sequence, copy number, conserved open reading frames, and similarity to keratin","volume":"29","author":"Demers","year":"1989","journal-title":"J Mol Evol"},{"issue":"6","key":"10.1016\/j.biologicals.2026.101913_bib11","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20190596","article-title":"Accurately cleavable goat \u03b2-lactoglobulin signal peptide efficiently guided translation of a recombinant human plasminogen activator in transgenic rabbit mammary gland","volume":"39","author":"Lu","year":"2019","journal-title":"Biosci Rep"},{"issue":"3\u20135","key":"10.1016\/j.biologicals.2026.101913_bib12","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S1050-3862(99)00024-8","article-title":"Transgenic rabbits for the production of biologically-active recombinant proteins in the milk","volume":"15","author":"Castro","year":"1999","journal-title":"Genet Anal"},{"issue":"8","key":"10.1016\/j.biologicals.2026.101913_bib13","first-page":"36","article-title":"Production of recombinant therapeutic proteins in the milk of transgenic animals","volume":"19","author":"Echelard","year":"2006","journal-title":"Biopharm Int"},{"issue":"1","key":"10.1016\/j.biologicals.2026.101913_bib14","first-page":"48","article-title":"Hereditary angioedema: a review. WMJ : official publication of the state medical society of Wisconsin","volume":"121","author":"Zafra","year":"2022"},{"issue":"2","key":"10.1016\/j.biologicals.2026.101913_bib15","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/bit.23343","article-title":"Residual DNA analysis in biologic development: review of measurement and quantitation technologies and future directions","volume":"109","author":"Wang","year":"2012","journal-title":"Biotechnol Bioeng"},{"issue":"2","key":"10.1016\/j.biologicals.2026.101913_bib16","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.biologicals.2013.10.005","article-title":"Quantitative detection of residual porcine host cell DNA by real-time PCR","volume":"42","author":"Chang","year":"2014","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2026.101913_bib17","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.biologicals.2019.09.004","article-title":"Method validation of Q-PCR detection of host residual DNA in antibody drug based on protein A magnetic beads","volume":"62","author":"Liu","year":"2019","journal-title":"Biologicals"},{"issue":"3","key":"10.1016\/j.biologicals.2026.101913_bib18","first-page":"279","article-title":"Applications of quantitative PCR in the biosafety and genetic stability assessment of biotechnology products","volume":"82","author":"Lovatt","year":"2002","journal-title":"J Biotechnol"},{"key":"10.1016\/j.biologicals.2026.101913_bib21","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.biologicals.2017.09.001","article-title":"Validation of a PCR coupled to a microarray method for detection of mycoplasma in vaccines","volume":"50","author":"Abachin","year":"2017","journal-title":"Biologicals"},{"issue":"4","key":"10.1016\/j.biologicals.2026.101913_bib20","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1373\/clinchem.2008.112797","article-title":"The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments","volume":"55","author":"Bustin","year":"2009","journal-title":"Clin Chem"},{"issue":"1","key":"10.1016\/j.biologicals.2026.101913_bib19","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1480-9222-15-5","article-title":"Fragmentation of DNA affects the accuracy of the DNA quantitation by the commonly used methods","volume":"15","author":"Sedlackova","year":"2013","journal-title":"Biol Proced Online"},{"key":"10.1016\/j.biologicals.2026.101913_bib23","series-title":"Validation of analytical procedures: text and methodology Q2(R1)","year":"2005"},{"issue":"3","key":"10.1016\/j.biologicals.2026.101913_bib22","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.biologicals.2016.03.002","article-title":"Universal real-time PCR assay for quantitation and size evaluation of residual cell DNA in human viral vaccines","volume":"44","author":"Andr\u00e9","year":"2016","journal-title":"Biologicals"},{"issue":"12","key":"10.1016\/j.biologicals.2026.101913_bib24","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.3390\/vaccines12121379","article-title":"Evaluation of the efficacy of the vaccine production process in removing residual host cell DNA from the Vero cell rabies vaccine","volume":"12","author":"Li","year":"2024","journal-title":"Vaccines"}],"container-title":["Biologicals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105626000412?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105626000412?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:07:54Z","timestamp":1793034474000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1045105626000412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":23,"alternative-id":["S1045105626000412"],"URL":"https:\/\/doi.org\/10.1016\/j.biologicals.2026.101913","relation":{},"ISSN":["1045-1056"],"issn-type":[{"value":"1045-1056","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and validation of a quantitative real-time PCR method for determination of residual host DNA in recombinant human C1 esterase inhibitor (rhC1INH)","name":"articletitle","label":"Article Title"},{"value":"Biologicals","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biologicals.2026.101913","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Alliance for Biological Standardization. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101913"}}